Cohort | Treatment response | All patients | Number of non-metastatic SLN ≥ 3 |
---|---|---|---|
GSH-YCC | Complete MRI response | 0.0% (0 of 5) | 0.0% (0 of 1) |
Non-complete MRI response | 36.7% (11 of 30) | 20.0% (1 of 5) | |
Total | 31.4% (11 of 35) | 16.7% (1 of 6) | |
AMC-SMC | Complete MRI response | 21.1% (4 of 19) | 0.0% (0 of 8) |
Non-complete MRI response | 30.8% (24 of 78) | 17.6% (6 of 34) | |
Total | 28.9% (28 of 97) | 14.3% (6 of 42) |